Dr Nick McMahon
VP, Mechanistic Safety and Disposition
GlaxoSmithKline
Research Interests
Safety, Translation, Metabolism, Toxicology, Pharmacology
As novel technology to assess drug safety and disposition properties of new medicines and to translate these data to human trials.